Editor's Note: It was learned from the Ministry of Industry and Information Technology on September 2 that on August 31, the Ministry of Industry and Information Technology and the National Health and Family Planning Commission jointly held a symposium on promoting the development and application of domestic medical equipment in Beijing and signed a cooperation agreement. Miao Wei, Minister of the Ministry of Industry and Information Technology, and Li Bin, Director of the National Health and Family Planning Commission, attended and spoke. The meeting was chaired by Li Bin, Director of the National Health and Family Planning Commission. Miao Wei stressed that the medical equipment industry is a sunrise industry with capital-intensive technology, large industrial relevance, strong driving force and broad development prospects. To promote the development of the domestic medical equipment industry, we must closely focus on the development needs of the health and family planning business and the overall deployment of the "1+X" program of "Made in China 2025", the whole industry chain design, and "one-stop" overall support. The stock market is risky and investment needs to be cautious. The articles mentioned in the article are for reference only and are not recommended for trading.

The two ministries jointly promote the development and application of domestic medical equipment

On September 1st, it was learned from the Ministry of Industry and Information Technology that on August 31, the Ministry of Industry and Information Technology and the National Health and Family Planning Commission jointly held a symposium on promoting the development and application of domestic medical equipment in Beijing and signed a cooperation agreement. Miao Wei, Minister of the Ministry of Industry and Information Technology, and Li Bin, Director of the National Health and Family Planning Commission, attended and spoke. The meeting was chaired by Li Bin, Director of the National Health and Family Planning Commission.

Miao Wei stressed that the medical equipment industry is a sunrise industry with capital-intensive technology, large industrial relevance, strong driving force and broad development prospects. To promote the development of the domestic medical equipment industry, we must closely focus on the development needs of the health and family planning business and the overall deployment of the "1+X" program of "Made in China 2025", the whole industry chain design, and "one-stop" overall support.

The nursery requires to focus on the innovation chain and the application chain. The innovation chain should integrate the upstream and downstream resources of the Ministry of Industry and Information Technology, coordinate and coordinate, focus on supporting a number of advantageous enterprises, and break through a number of key medical equipment and cores. Components and software significantly improve the industrialization capability and quality level of domestic medical equipment; the application chain should be closely integrated with the relevant work and policy measures of the National Health and Family Planning Commission to promote a number of domestic medical equipment to enter the influential hospitals for application and Comparative verification, the establishment of a number of domestic medical equipment application demonstration base. Miao Wei pointed out that it is necessary to strengthen cooperation and communication with local governments, actively understand and learn from local good practices, and introduce some pilot measures to focus on selecting a group of well-established provinces (cities) to carry out pilot work.

Li Bin demanded that the Health and Family Planning Commission should actively take measures to implement the cooperation agreement. First, we must adhere to mechanism innovation and do top-level design; second, we must adhere to technological innovation and enhance the core competitiveness of domestically produced equipment. It is necessary to guide the establishment of medical institutions to participate in the research and development, innovation and application of domestic medical equipment through policy funding, and form a virtuous cycle between innovation and application. Third, we must adhere to the problem-oriented and focus on solving the difficulties and obstacles that restrict the development and application of domestic equipment. It is necessary to carefully analyze every link of production, education and research, and take targeted measures to establish and improve the incentive mechanism for medical and health institutions to actively use domestically produced equipment. Fourth, we must adhere to the international perspective and further promote the domestic equipment to go out; Really work hard and implement the cooperation agreement.

The meeting requested that under the good cooperation of the two ministries and commissions, it is necessary to further strengthen communication and coordination with other departments, strive to promote the implementation of the support policies and measures for the development and application of the domestic equipment industry, and form a joint effort to jointly create a whole society to support domestic equipment. A good social environment for industrial development.

Xin Guobin, deputy director of the Ministry of Industry and Information Technology, and Sun Zhigang, deputy director of the National Health and Family Planning Commission, signed a cooperation agreement on promoting the development and application of domestic medical equipment on behalf of the two ministries.

According to industry insiders, the potential and space for medical device development is huge. At present, domestic medical equipment accounts for less than 10% of the domestic market. In the next 10 to 15 years, domestic medical devices are expected to reach a market share of more than 50%. With the large amount of funds invested by medical institutions at all levels to purchase medical equipment, it is expected that the domestic market of medical equipment will continue to expand during the “13th Five-Year Plan” period. The two ministries signed an agreement to jointly promote the application of domestic medical equipment, which is undoubtedly a major positive for the industry.

In May of this year, among the A-share companies, 7 listed companies including China Resources Wandong, Xinhua Medical, Dirui Medical, Hejia, Neusoft, New Huangpu and Kehua Biological were selected for the first batch of excellent domestic medical equipment catalogues. The future is expected to take the lead.

On July 29th, in the "Chao Wen Tian Xia" and "News Live" programs broadcast by CCTV News Channel, the topic of " precise medical care " was reported in a large part. The moderator and program group introduced the concept, development and application of “precise medical care” in detail, and revealed that China is preparing to build its own genome-wide database and sample database to lay the foundation for precision medicine.

On May 19th, "Made in China 2025" was unveiled, and the top ten industries such as biomedicine and high-performance medical devices were upgraded to "national strategy." Analysts in the pharmaceutical industry pointed out: "Under the promotion of technological innovation, heavy new drugs and high-end medical device industry will usher in a new development space. The investment and declaration of listed companies on innovative drug research and development will gradually increase; the process of localization of medical devices It is also expected to accelerate."

On July 12, Sang Guowei, an academician of the Chinese Academy of Engineering, revealed at the 2015 (32nd) National Pharmaceutical Industry Information Annual Meeting that according to the deployment and requirements of the major special offices of the Ministry of Science and Technology, the new drug special project has started the development of the “13th Five-Year Plan”. Strategic research and implementation plan preparation.

Tiamulin Fumarate Soluble Powder

Tiamulin Powder,Tiamulin Soluble Powder,Tiamulin Hydrogen Fumarate Powder,Tiamulin Animal Drug

Shandong Shengli Bioengineering Co., Ltd , https://www.shenglipharm.com